128 related articles for article (PubMed ID: 15356995)
21. Decreased in vivo metabolism of drugs in chronic renal failure.
Leblond FA; Giroux L; Villeneuve JP; Pichette V
Drug Metab Dispos; 2000 Nov; 28(11):1317-20. PubMed ID: 11038159
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of bromodichloromethane metabolism by cytochrome P450 isoenzymes in human liver microsomes.
Zhao G; Allis JW
Chem Biol Interact; 2002 May; 140(2):155-68. PubMed ID: 12076522
[TBL] [Abstract][Full Text] [Related]
23. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition.
Kim YG; Cho MK; Kwon JW; Kim SG; Chung SJ; Shim CK; Le Myung G
Biopharm Drug Dispos; 2002 Apr; 23(3):121-9. PubMed ID: 12173547
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of theophylline in protein-calorie malnutrition.
Jung D
Biopharm Drug Dispos; 1985; 6(3):291-9. PubMed ID: 3929852
[TBL] [Abstract][Full Text] [Related]
25. [Effect of carbon tetrachloride-induced hepatic injury on stereoselective N-demethylation of chlorpheniramine by rat hepatic cytochrome P450 2C11 isozyme].
Nomura A; Sakurai E; Hikichi N
Yakugaku Zasshi; 1998 Aug; 118(8):317-23. PubMed ID: 9739616
[TBL] [Abstract][Full Text] [Related]
26. No effect of cysteine on the pharmacokinetics of intravenous azosemide in rats with protein-calorie malnutrition by pretreatment with 3-methylcholanthrene.
Kim YG; Cho MK; Kwon JW; Kim SH; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):347-60. PubMed ID: 12889526
[TBL] [Abstract][Full Text] [Related]
27. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.
Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K
Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms.
Subrahmanyam V; Renwick AB; Walters DG; Price RJ; Tonelli AP; Lake BG
Xenobiotica; 2002 Jun; 32(6):521-34. PubMed ID: 12160484
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hepatic cytochrome P450 isozyme composition in the transgenic rat expressing low level human growth hormone.
Takahashi J; Furuhata Y; Ikeda A; Takahashi M; Iwata H; Kazusaka A; Fujita S
Xenobiotica; 1999 Dec; 29(12):1203-12. PubMed ID: 10647907
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes.
Park JY; Kim KA
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):407-9. PubMed ID: 12904931
[TBL] [Abstract][Full Text] [Related]
31. Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats.
Oh SJ; Choi JM; Yun KU; Oh JM; Kwak HC; Oh JG; Lee KS; Kim BH; Heo TH; Kim SK
Chem Biol Interact; 2012 Feb; 195(3):173-9. PubMed ID: 22244987
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
34. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition.
Kim YG; Cho MK; Kwon JW; Kim SG; Kim SH; Lee MG
Life Sci; 2001 Apr; 68(21):2329-45. PubMed ID: 11350005
[TBL] [Abstract][Full Text] [Related]
35. Predicting drug pharmacokinetics in humans from in vitro metabolism studies.
McGinnity DF; Riley RJ
Biochem Soc Trans; 2001 May; 29(Pt 2):135-9. PubMed ID: 11356141
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.
Lee SH; Slattery JT
Drug Metab Dispos; 1997 Dec; 25(12):1354-8. PubMed ID: 9394024
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil.
Afsar A; Lee C; Riddick DS
Can J Physiol Pharmacol; 1996 Feb; 74(2):150-6. PubMed ID: 8723027
[TBL] [Abstract][Full Text] [Related]
38. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes.
Nomura A; Sakurai E; Hikichi N
J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341
[TBL] [Abstract][Full Text] [Related]
39. Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin.
Vuppugalla R; Shah RB; Chimalakonda AP; Fisher CW; Mehvar R
Pharm Res; 2003 Jan; 20(1):81-8. PubMed ID: 12608540
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
